Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-097370

Chief Development Officer sold 4,879 shares at an average $73.48 ($358,495)

  • Chief Development Officer acquired 4,879 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Guyer William Chief Development Officer 2025-07-17 Option exercise 10b5-1 +4,379 $21.65 $94,805 9,866 D: show line 1 in the form
Guyer William Chief Development Officer 2025-07-17 Sale 10b5-1 −4,379 $73.48 $321,774 5,487 D: show line 2 in the form
Guyer William Chief Development Officer 2025-07-18 Option exercise 10b5-1 +500 $21.65 $10,825 5,987 D: show line 3 in the form
Guyer William Chief Development Officer 2025-07-18 Sale 10b5-1 −500 $73.44 $36,721 5,487 D: show line 4 in the form
Open-market sales · 4,879 sh · avg $73.48 · $358,495

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Guyer William Chief Development Officer 2025-07-17 Option exercise · Stock option (right to buy) 10b5-1 −4,379 385,521 D: show line 5 in the form
Guyer William Chief Development Officer 2025-07-18 Option exercise · Stock option (right to buy) 10b5-1 −500 385,021 D: show line 6 in the form
Loading xslF345X05/ownership.xml…